Home › Companies › ANI Pharmaceuticals, Inc. › 2024-2025

ANI Pharmaceuticals, Inc. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and ANI Pharmaceuticals, Inc.’s Form 8-K, filed May 23, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.

  • 14Reported items
  • 266Asset managers
  • 3,717Fund votes
  • May 22, 2025Meeting date

Results at a glance

Meeting of May 22, 2025: 13 items on ANI Pharmaceuticals, Inc.’s Form 8-K, filed May 23, 2025: 13 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore ANI Pharmaceuticals, Inc. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by ANI Pharmaceuticals, Inc.

These tallies are ANI Pharmaceuticals, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 23, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ANI Pharmaceuticals, Inc. — official shareholder meeting results, meeting held May 22, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Thomas Haughey 15,977,793285,2777,168 --2,151,848 98%Not verified—
Elect Director: Nikhil Lalwani 16,238,47427,6184,146 --2,151,848 99.8%Not verified—
Elect Director: Matthew J. Leonard, R.Ph. 15,996,996266,0747,168 --2,151,848 98%Not verified—
Elect Director: Antonio R. Pera 15,507,112755,8087,318 --2,151,848 95%Not verified—
Elect Director: Muthusamy Shanmugam 16,202,75363,0274,458 --2,151,848 99.6%Not verified—
Elect Director: Renee P. Tannenbaum, Pharm.D. 14,548,2001,368,462353,576 --2,151,848 91%Not verified—
Elect Director: Jeanne A. Thoma 15,581,643684,6343,961 --2,151,848 96%Not verified—
Elect Director: Patrick D. Walsh 16,145,463120,7973,978 --2,151,848 99.2%Not verified—
2. Ratification of the Appointment of Independent Registered Public Accounting Firm The vote with respect to the ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending Decemb 18,376,99437,3437,749 ---- 99.7%Not verified—
3. Approval of the Say-on-Pay Proposal The vote with respect to the approval of the Company's named executive officers, on an advisory basis 14,565,5871,689,47715,174 --2,151,848 90%Not verified—
4. Approval of an Amendment to the Company's Restated Certificate of Incorporation The vote with respect to the approval of an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 33, 17,950,106461,82410,156 ---- 97%Not verified—
5. Approval of the Amended 2022 Stock Plan The vote with respect to the approval of the Amended 2022 Stock Plan 15,056,8851,202,89310,460 --2,151,848 93%Not verified—
6. Approval of the Amended 2016 Employee Stock Purchase Plan The vote with respect to the approval of the Amended 2016 Employee Stock Purchase Plan 16,173,97689,0987,164 --2,151,848 99.4%Not verified—

Source: ANI Pharmaceuticals, Inc., Form 8-K, filed with the SEC on May 23, 2025 — read the filing on EDGAR.

How asset managers voted at the ANI Pharmaceuticals, Inc. 2024-2025 meeting

Each item below shows how the 266 asset managers that disclosed a ANI Pharmaceuticals, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ANI Pharmaceuticals, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Antonio R. Pera

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 15,507,112AGAINST: 755,808
Details: description as filed, official tally, votes by 81 asset managers

Description as filed by funds: Election of Directors: Antonio R. Pera

ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Antonio R. Pera”): 15,507,112 for, 755,808 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 81 asset managers below reported 6,422,460 for, 133 against, 1,630 abstained.

FOR
FOR: 6,422,460AGAINST: 133ABSTAIN: 1,630
Largest asset managers voting on “Election of Directors: Antonio R. Pera” at ANI Pharmaceuticals, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,605,9720 00For
Vanguard1,176,5781 00For
Fidelity391,7230 00For
Dimensional387,8940 00For
Columbia Threadneedle309,5450 00For
State Street297,2760 00For
Waddell & Reed275,9410 00For
Charles Schwab210,5730 00For
WILLIAM BLAIR FUNDS201,9900 00For
Aberdeen175,0200 00For
Invesco96,9370 00For
World Funds Trust84,3060 00For
Russell Investments82,2800 00For
Empower78,7750 00For
JPMorgan72,5760 00For
OBERWEIS FUNDS65,6000 00For
Brighthouse60,4010 1,6300For
SEI51,2920 00For
Loomis Sayles49,6760 00For
Equitable47,7450 00For
TIAA47,5810 00For
Ivy Variable Insurance Portfolios47,0360 00For
Securian Funds Trust36,8270 00For
First Trust35,0500 00For
Jackson National34,6870 00For

Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.

2. Elect Director: Jeanne A. Thoma

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 15,581,643AGAINST: 684,634
Details: description as filed, official tally, votes by 81 asset managers

Description as filed by funds: Election of Directors: Jeanne A Thoma

ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Jeanne A. Thoma”): 15,581,643 for, 684,634 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 81 asset managers below reported 6,422,460 for, 133 against, 1,630 abstained.

FOR
FOR: 6,422,460AGAINST: 133ABSTAIN: 1,630
Largest asset managers voting on “Election of Directors: Jeanne A Thoma” at ANI Pharmaceuticals, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,605,9720 00For
Vanguard1,176,5781 00For
Fidelity391,7230 00For
Dimensional387,8940 00For
Columbia Threadneedle309,5450 00For
State Street297,2760 00For
Waddell & Reed275,9410 00For
Charles Schwab210,5730 00For
WILLIAM BLAIR FUNDS201,9900 00For
Aberdeen175,0200 00For
Invesco96,9370 00For
World Funds Trust84,3060 00For
Russell Investments82,2800 00For
Empower78,7750 00For
JPMorgan72,5760 00For
OBERWEIS FUNDS65,6000 00For
Brighthouse60,4010 1,6300For
SEI51,2920 00For
Loomis Sayles49,6760 00For
Equitable47,7450 00For
TIAA47,5810 00For
Ivy Variable Insurance Portfolios47,0360 00For
Securian Funds Trust36,8270 00For
First Trust35,0500 00For
Jackson National34,6870 00For

Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.

3. Elect Director: Matthew J. Leonard, R.Ph.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 15,996,996AGAINST: 266,074
Details: description as filed, official tally, votes by 81 asset managers

Description as filed by funds: Election of Directors: Matthew J. Leonard, R.Ph.

ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Matthew J. Leonard, R.Ph.”): 15,996,996 for, 266,074 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 81 asset managers below reported 6,421,130 for, 1,463 against, 1,630 abstained.

FOR
FOR: 6,421,130AGAINST: 1,463ABSTAIN: 1,630
Largest asset managers voting on “Election of Directors: Matthew J. Leonard, R.Ph.” at ANI Pharmaceuticals, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,605,9720 00For
Vanguard1,176,102477 00For
Fidelity391,7230 00For
Dimensional387,8940 00For
Columbia Threadneedle309,5450 00For
State Street297,2760 00For
Waddell & Reed275,9410 00For
Charles Schwab210,5730 00For
WILLIAM BLAIR FUNDS201,9900 00For
Aberdeen175,0200 00For
Invesco96,9370 00For
World Funds Trust84,3060 00For
Russell Investments82,2800 00For
Empower78,7750 00For
JPMorgan72,5760 00For
OBERWEIS FUNDS65,6000 00For
Brighthouse60,4010 1,6300For
SEI51,2920 00For
Loomis Sayles49,6760 00For
Equitable47,7450 00For
TIAA47,5810 00For
Ivy Variable Insurance Portfolios47,0360 00For
Securian Funds Trust36,8270 00For
First Trust35,0500 00For
Jackson National34,6870 00For

Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.

4. Elect Director: Muthusamy Shanmugam

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 16,202,753AGAINST: 63,027
Details: description as filed, official tally, votes by 81 asset managers

Description as filed by funds: Election of Directors: Muthusamy Shanmugam

ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Muthusamy Shanmugam”): 16,202,753 for, 63,027 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 81 asset managers below reported 6,422,593 for, 0 against, 1,630 abstained.

FOR
FOR: 6,422,593AGAINST: 0ABSTAIN: 1,630
Largest asset managers voting on “Election of Directors: Muthusamy Shanmugam” at ANI Pharmaceuticals, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,605,9720 00For
Vanguard1,176,5790 00For
Fidelity391,7230 00For
Dimensional387,8940 00For
Columbia Threadneedle309,5450 00For
State Street297,2760 00For
Waddell & Reed275,9410 00For
Charles Schwab210,5730 00For
WILLIAM BLAIR FUNDS201,9900 00For
Aberdeen175,0200 00For
Invesco96,9370 00For
World Funds Trust84,3060 00For
Russell Investments82,2800 00For
Empower78,7750 00For
JPMorgan72,5760 00For
OBERWEIS FUNDS65,6000 00For
Brighthouse60,4010 1,6300For
SEI51,2920 00For
Loomis Sayles49,6760 00For
Equitable47,7450 00For
TIAA47,5810 00For
Ivy Variable Insurance Portfolios47,0360 00For
Securian Funds Trust36,8270 00For
First Trust35,0500 00For
Jackson National34,6870 00For

Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.

5. Elect Director: Nikhil Lalwani

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 16,238,474AGAINST: 27,618
Details: description as filed, official tally, votes by 81 asset managers

Description as filed by funds: Election of Directors: Nikhil Lalwani

ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Nikhil Lalwani”): 16,238,474 for, 27,618 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 81 asset managers below reported 6,422,593 for, 0 against, 1,630 abstained.

FOR
FOR: 6,422,593AGAINST: 0ABSTAIN: 1,630
Largest asset managers voting on “Election of Directors: Nikhil Lalwani” at ANI Pharmaceuticals, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,605,9720 00For
Vanguard1,176,5790 00For
Fidelity391,7230 00For
Dimensional387,8940 00For
Columbia Threadneedle309,5450 00For
State Street297,2760 00For
Waddell & Reed275,9410 00For
Charles Schwab210,5730 00For
WILLIAM BLAIR FUNDS201,9900 00For
Aberdeen175,0200 00For
Invesco96,9370 00For
World Funds Trust84,3060 00For
Russell Investments82,2800 00For
Empower78,7750 00For
JPMorgan72,5760 00For
OBERWEIS FUNDS65,6000 00For
Brighthouse60,4010 1,6300For
SEI51,2920 00For
Loomis Sayles49,6760 00For
Equitable47,7450 00For
TIAA47,5810 00For
Ivy Variable Insurance Portfolios47,0360 00For
Securian Funds Trust36,8270 00For
First Trust35,0500 00For
Jackson National34,6870 00For

Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.

6. Elect Director: Renee P. Tannenbaum, Pharm.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%
FOR: 14,548,200AGAINST: 1,368,462
Details: description as filed, official tally, votes by 81 asset managers

Description as filed by funds: Election of Directors: Renee P. Tannenbaum, Pharm.D.

ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Renee P. Tannenbaum, Pharm.D.”): 14,548,200 for, 1,368,462 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 81 asset managers below reported 5,749,835 for, 363,212 against, 311,176 abstained.

FOR
FOR: 5,749,835AGAINST: 363,212ABSTAIN: 311,176
Largest asset managers voting on “Election of Directors: Renee P. Tannenbaum, Pharm.D.” at ANI Pharmaceuticals, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,605,9720 00For
Vanguard1,176,100478 10For
Fidelity391,7230 00For
Dimensional387,8940 00For
Columbia Threadneedle00 309,5450Abstain
State Street297,2760 00For
Waddell & Reed0275,941 00Against
Charles Schwab210,5730 00For
WILLIAM BLAIR FUNDS201,9900 00For
Aberdeen175,0200 00For
Invesco96,9370 00For
World Funds Trust84,3060 00For
Russell Investments82,2800 00For
Empower78,7750 00For
JPMorgan72,5760 00For
OBERWEIS FUNDS65,6000 00For
Brighthouse60,4010 1,6300For
SEI51,2920 00For
Loomis Sayles49,6760 00For
Equitable47,7450 00For
TIAA47,5810 00For
Ivy Variable Insurance Portfolios047,036 00Against
Securian Funds Trust036,827 00Against
First Trust35,0500 00For
Jackson National34,6870 00For

Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.

7. Elect Director: Thomas Haughey

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 15,977,793AGAINST: 285,277
Details: description as filed, official tally, votes by 81 asset managers

Description as filed by funds: Election of Directors: Thomas J. Haughey

ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Thomas Haughey”): 15,977,793 for, 285,277 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 81 asset managers below reported 6,421,130 for, 1,463 against, 1,630 abstained.

FOR
FOR: 6,421,130AGAINST: 1,463ABSTAIN: 1,630
Largest asset managers voting on “Election of Directors: Thomas J. Haughey” at ANI Pharmaceuticals, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,605,9720 00For
Vanguard1,176,102477 00For
Fidelity391,7230 00For
Dimensional387,8940 00For
Columbia Threadneedle309,5450 00For
State Street297,2760 00For
Waddell & Reed275,9410 00For
Charles Schwab210,5730 00For
WILLIAM BLAIR FUNDS201,9900 00For
Aberdeen175,0200 00For
Invesco96,9370 00For
World Funds Trust84,3060 00For
Russell Investments82,2800 00For
Empower78,7750 00For
JPMorgan72,5760 00For
OBERWEIS FUNDS65,6000 00For
Brighthouse60,4010 1,6300For
SEI51,2920 00For
Loomis Sayles49,6760 00For
Equitable47,7450 00For
TIAA47,5810 00For
Ivy Variable Insurance Portfolios47,0360 00For
Securian Funds Trust36,8270 00For
First Trust35,0500 00For
Jackson National34,6870 00For

Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.

8. Election of Directors: Patrick D. Wash

No official matchDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: votes by 53 asset managers

The 53 asset managers below reported 4,043,554 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 4,043,554
Largest asset managers voting on “Election of Directors: Patrick D. Wash” at ANI Pharmaceuticals, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,175,0920 00For
Fidelity391,7230 00For
Dimensional387,8940 00For
Columbia Threadneedle309,5450 00For
State Street297,2760 00For
Waddell & Reed275,9410 00For
WILLIAM BLAIR FUNDS201,9900 00For
Aberdeen175,0200 00For
Invesco96,9370 00For
OBERWEIS FUNDS65,6000 00For
Empower60,7570 00For
Brighthouse60,4010 00For
Equitable47,7450 00For
TIAA47,5810 00For
Ivy Variable Insurance Portfolios47,0360 00For
First Trust35,0500 00For
Principal33,7200 00For
HOTCHKIS & WILEY FUNDS /DE/28,5000 00For
Transamerica26,7160 00For
American Century25,9810 00For
Lincoln Financial25,8060 00For
AIG/SunAmerica21,6940 00For
Northern Trust18,4270 00For
BNY Mellon17,9530 00For
SPEND LIFE WISELY FUNDS INVESTMENT TRUST16,5410 00For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

9. Elect Director: Patrick D. Walsh

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 16,145,463AGAINST: 120,797
Details: description as filed, official tally, votes by 34 asset managers

Description as filed by funds: Election of Director: Patrick D. Walsh

ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Patrick D. Walsh”): 16,145,463 for, 120,797 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 34 asset managers below reported 2,378,563 for, 476 against, 1,630 abstained.

FOR
FOR: 2,378,563AGAINST: 476ABSTAIN: 1,630
Largest asset managers voting on “Election of Director: Patrick D. Walsh” at ANI Pharmaceuticals, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,605,9720 00For
Charles Schwab210,5730 00For
World Funds Trust84,3060 00For
Russell Investments82,2800 00For
JPMorgan72,5760 00For
SEI51,2920 00For
Loomis Sayles49,6760 00For
Securian Funds Trust36,8270 00For
Jackson National34,6870 00For
QUANTITATIVE MASTER SERIES LLC31,8710 00For
CARILLON SERIES TRUST25,5100 00For
Empower18,0180 00For
Prudential/PGIM14,7800 00For
Global X10,9810 00For
SEI Exchange Traded Funds8,7180 00For
John Hancock7,4510 00For
Allianz6,1900 00For
RBB FUND, INC.5,2760 00For
ADVISORS' INNER CIRCLE FUND4,9180 00For
Bridge Builder Trust4,8670 00For
New York Life3,8720 00For
NORTHERN LIGHTS FUND TRUST II2,5500 00For
Brighthouse00 1,6300Abstain
Vanguard1,011476 00Mixed
GPS Funds I1,2530 00For

Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.

10. 4. Approval of an Amendment to the Company's Restated Certificate of Incorporation The vote with respect to the…

Outcome not verifiedCAPITAL STRUCTUREReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 17,950,106AGAINST: 461,824
Details: description as filed, official tally, votes by 81 asset managers

Description as filed by funds: To approve an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of common stock.

ANI Pharmaceuticals, Inc.’s own tally for this item (“4. Approval of an Amendment to the Company's Restated Certificate of Incorporation The vote with respect to the approval of an amendment to the Company's Restated Certificate of Incorporation to increase the number of au”): 17,950,106 for, 461,824 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 81 asset managers below reported 6,405,942 for, 18,281 against, 0 abstained.

FOR
FOR: 6,405,942AGAINST: 18,281ABSTAIN: 0
Largest asset managers voting on “To approve an amendment to the Company's Restated Certificate of Incorporation to increase the number of autho” at ANI Pharmaceuticals, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,605,9720 00For
Vanguard1,176,5790 00For
Fidelity391,7230 00For
Dimensional387,8940 00For
Columbia Threadneedle309,5450 00For
State Street297,26610 00For
Waddell & Reed275,9410 00For
Charles Schwab210,5730 00For
WILLIAM BLAIR FUNDS201,9900 00For
Aberdeen175,0200 00For
Invesco96,9370 00For
World Funds Trust84,3060 00For
Russell Investments82,2800 00For
Empower78,7750 00For
JPMorgan72,5760 00For
OBERWEIS FUNDS65,6000 00For
Brighthouse60,4011,630 00For
SEI51,2920 00For
Loomis Sayles49,6760 00For
Equitable47,7450 00For
TIAA47,5810 00For
Ivy Variable Insurance Portfolios47,0360 00For
Securian Funds Trust36,8270 00For
First Trust35,0500 00For
Jackson National34,6870 00For

Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.

11. 6. Approval of the Amended 2016 Employee Stock Purchase Plan The vote with respect to the approval of the Amended 2016…

Outcome not verifiedCOMPENSATIONReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 16,173,976AGAINST: 89,098
Details: description as filed, official tally, votes by 82 asset managers

Description as filed by funds: To approve the Amended and Restated 2016 Employee Stock Purchase Plan.

ANI Pharmaceuticals, Inc.’s own tally for this item (“6. Approval of the Amended 2016 Employee Stock Purchase Plan The vote with respect to the approval of the Amended 2016 Employee Stock Purchase Plan”): 16,173,976 for, 89,098 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 82 asset managers below reported 6,408,257 for, 16,410 against, 0 abstained.

FOR
FOR: 6,408,257AGAINST: 16,410ABSTAIN: 0
Largest asset managers voting on “To approve the Amended and Restated 2016 Employee Stock Purchase Plan.” at ANI Pharmaceuticals, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,605,9720 00For
Vanguard1,176,5790 00For
Fidelity391,7230 00For
Dimensional387,8940 00For
Columbia Threadneedle309,5450 00For
State Street297,2760 00For
Waddell & Reed275,9410 00For
Charles Schwab210,5730 00For
WILLIAM BLAIR FUNDS201,9900 00For
Aberdeen175,0200 00For
Invesco96,9370 00For
World Funds Trust84,3060 00For
Russell Investments82,2800 00For
Empower78,7750 00For
JPMorgan72,5760 00For
OBERWEIS FUNDS65,6000 00For
Brighthouse60,4011,630 00For
SEI51,2920 00For
Loomis Sayles49,6760 00For
Equitable47,7450 00For
TIAA47,5810 00For
Ivy Variable Insurance Portfolios47,0360 00For
Securian Funds Trust36,8270 00For
First Trust35,0500 00For
Jackson National34,6870 00For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

12. 5. Approval of the Amended 2022 Stock Plan The vote with respect to the approval of the Amended 2022 Stock Plan

Outcome not verifiedCOMPENSATIONReported outcome: Not verified

93% Majority: yes · of votes cast

FOR 93%
FOR: 15,056,885AGAINST: 1,202,893
Details: description as filed, official tally, votes by 80 asset managers

Description as filed by funds: To approve the Amended and Restated 2022 Stock Incentive Plan.

ANI Pharmaceuticals, Inc.’s own tally for this item (“5. Approval of the Amended 2022 Stock Plan The vote with respect to the approval of the Amended 2022 Stock Plan”): 15,056,885 for, 1,202,893 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 80 asset managers below reported 6,297,108 for, 106,339 against, 2,216 abstained.

FOR
FOR: 6,297,108AGAINST: 106,339ABSTAIN: 2,216
Largest asset managers voting on “To approve the Amended and Restated 2022 Stock Incentive Plan.” at ANI Pharmaceuticals, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,605,9720 00For
Vanguard1,176,5772 00For
Fidelity391,7230 00For
Dimensional387,8940 00For
Columbia Threadneedle309,5450 00For
State Street297,26412 00For
Waddell & Reed275,9410 00For
Charles Schwab210,5730 00For
WILLIAM BLAIR FUNDS201,9900 00For
Aberdeen175,0200 00For
Invesco96,9370 00For
World Funds Trust6,35077,956 00Mixed
Russell Investments82,2800 00For
JPMorgan72,5760 00For
OBERWEIS FUNDS65,6000 00For
Brighthouse60,4010 1,6300For
Empower60,7570 00For
SEI51,2920 00For
Loomis Sayles49,6760 00For
Equitable47,7450 00For
TIAA47,5810 00For
Ivy Variable Insurance Portfolios47,0360 00For
Securian Funds Trust36,8270 00For
First Trust35,0500 00For
Jackson National34,6870 00For

Showing the 25 largest of 80 asset managers. See all 80 in the interactive database.

13. 3. Approval of the Say-on-Pay Proposal The vote with respect to the approval of the Company's named executive officers…

Outcome not verifiedFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 9 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%
FOR: 14,565,587AGAINST: 1,689,477
Details: description as filed, official tally, votes by 266 asset managers

Description as filed by funds: To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis.

ANI Pharmaceuticals, Inc.’s own tally for this item (“3. Approval of the Say-on-Pay Proposal The vote with respect to the approval of the Company's named executive officers, on an advisory basis”): 14,565,587 for, 1,689,477 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 80 asset managers voting on “To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis.” at ANI Pharmaceuticals, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,605,9720 00For
Vanguard1,176,101478 00For
Fidelity391,7230 00For
Dimensional387,8940 00For
Columbia Threadneedle309,5450 00For
State Street297,2760 00For
Waddell & Reed275,9410 00For
Charles Schwab210,5730 00For
WILLIAM BLAIR FUNDS201,9900 00For
Aberdeen0175,020 00Against
Invesco096,937 00Against
World Funds Trust84,3060 00For
Russell Investments82,2800 00For
Empower78,7750 00For
JPMorgan72,5760 00For
OBERWEIS FUNDS65,6000 00For
Brighthouse60,4010 1,6300For
SEI51,2920 00For
Loomis Sayles49,6760 00For
Equitable47,7450 00For
TIAA47,5810 00For
Ivy Variable Insurance Portfolios47,0360 00For
Securian Funds Trust36,8270 00For
First Trust35,0500 00For
Jackson National5,56929,118 00Mixed

Fund voting reports, all 80 managers: 6,077,591 for, 360,687 against, 1,630 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 211 asset managers voting on “To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis.” at ANI Pharmaceuticals, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Deep Track Capital, LP773,8830 00For
State Street648,0130 00For
BlackRock590,922265 00For
Global Alpha Capital Management Ltd.0505,635 00Against
Ranger Investment Management, L.P.472,9080 00For
GEODE CAPITAL MANAGEMENT, LLC427,3050 00For
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST412,7720 00For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC401,8260 00For
Aberdeen0390,125 00Against
Citadel373,7050 00For
Charles Schwab227,8800 00For
Soleus Capital Management, L.P.226,9930 00For
KENNEDY CAPITAL MANAGEMENT LLC191,3280 00For
Loomis Sayles181,8360 00For
THOMPSON SIEGEL & WALMSLEY LLC177,5620 00For
Northern Trust175,4020 00For
Russell Investments167,8010 00For
Invesco0136,572 00Against
JPMorgan122,3950 00For
Renaissance119,2350 00For
MELLON INVESTMENTS Corp0115,018 00Against
PRINCIPAL GLOBAL INVESTORS96,0100 00For
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC90,0000 00For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM082,998 00Against
Woodline Partners LP82,1810 00For

Institutional-manager reports, all 211 managers: 7,308,055 for, 1,438,229 against, 0 not voted. Showing the 25 largest; see all in the interactive database.

14. 2. Ratification of the Appointment of Independent Registered Public Accounting Firm The vote with respect to the…

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 18,376,994AGAINST: 37,343
Details: description as filed, official tally, votes by 81 asset managers

Description as filed by funds: To ratify the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.

ANI Pharmaceuticals, Inc.’s own tally for this item (“2. Ratification of the Appointment of Independent Registered Public Accounting Firm The vote with respect to the ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accountin”): 18,376,994 for, 37,343 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 81 asset managers below reported 6,422,581 for, 12 against, 1,630 abstained.

FOR
FOR: 6,422,581AGAINST: 12ABSTAIN: 1,630
Largest asset managers voting on “To ratify the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm fo” at ANI Pharmaceuticals, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,605,9720 00For
Vanguard1,176,5790 00For
Fidelity391,7230 00For
Dimensional387,8940 00For
Columbia Threadneedle309,5450 00For
State Street297,26412 00For
Waddell & Reed275,9410 00For
Charles Schwab210,5730 00For
WILLIAM BLAIR FUNDS201,9900 00For
Aberdeen175,0200 00For
Invesco96,9370 00For
World Funds Trust84,3060 00For
Russell Investments82,2800 00For
Empower78,7750 00For
JPMorgan72,5760 00For
OBERWEIS FUNDS65,6000 00For
Brighthouse60,4010 1,6300For
SEI51,2920 00For
Loomis Sayles49,6760 00For
Equitable47,7450 00For
TIAA47,5810 00For
Ivy Variable Insurance Portfolios47,0360 00For
Securian Funds Trust36,8270 00For
First Trust35,0500 00For
Jackson National34,6870 00For

Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.

Largest ANI Pharmaceuticals, Inc. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 21,108,152 shares outstanding at the time of that meeting.

Fund voting reports: top ANI Pharmaceuticals, Inc. shareholders by shares voted on “To approve the compensation of the Company's named executive officers, on a non-binding…”, 2024-2025
#Asset manager % of shares outstanding
1BlackRock 7.61%
2Vanguard 5.57%
3Fidelity 1.86%
4Dimensional 1.84%
5Columbia Threadneedle 1.47%
6State Street 1.41%
7Waddell & Reed 1.31%
8Charles Schwab 1.00%
9WILLIAM BLAIR FUNDS 0.96%
10Aberdeen 0.83%
Institutional-manager reports: top ANI Pharmaceuticals, Inc. shareholders by shares voted on “To approve the compensation of the Company's named executive officers, on a non-binding…”, 2024-2025
#Asset manager % of shares outstanding
1Deep Track Capital, LP 3.67%
2State Street 3.07%
3BlackRock 2.80%
4Global Alpha Capital Management Ltd. 2.40%
5Ranger Investment Management, L.P. 2.24%
6GEODE CAPITAL MANAGEMENT, LLC 2.02%
7MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST 1.96%
8WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.90%
9Aberdeen 1.85%
10Citadel 1.77%

Reported ANI Pharmaceuticals, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

ANI Pharmaceuticals, Inc. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
BlackRock 12.54% 13F
Vanguard Group 5.60% 13F
Meridian Venture Partners II, L.P. 5.52% DEF14A
Integrated Core Strategies (US) LLC 5.25% 13G
Meridian Venture Partners II GP, L.P. ("GP") 4.81% 13D
Millennium Management 3.88% 13F
Citadel Advisors 3.48% 13F
Muthusamy Shanmugam 3.39% DEF14A
State Street 3.39% 13F
Goldman Sachs 2.99% 13F

Percentages above are of 21,108,152 shares outstanding, as reported by ANI Pharmaceuticals, Inc. on its Form 10-K dated December 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ANI Pharmaceuticals, Inc.’s 10-K dated December 31, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At ANI Pharmaceuticals, Inc.'s shareholder meeting held May 22, 2025, in the 2024-2025 proxy season, 266 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,717 separate fund positions. Their filings are grouped here into 14 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve the compensation of the Company's named executive officers, on a non-binding… — FOR was 90% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ANI Pharmaceuticals, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 23, 2025.

ANI Pharmaceuticals, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.